On the fibrinolytic and thrombolytic properties of active-site p-anisoylated streptokinase-plasminogen complex (BRL 26921).
D000818:Animals; D016255:Anistreplase; D000906:Antibodies; D001777:Blood Coagulation / Q000528:radiation effects; D004285:Dogs; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D010958:Plasminogen / Q000494:pharmacology* / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000209:etiology; D011817:Rabbits; D013300:Streptokinase / Q000276:immunology / Q000494:pharmacology* / Q000627:therapeutic use
D000906:Antibodies; D005343:Fibrinolytic Agents; D016255:Anistreplase; D010958:Plasminogen; D013300:Streptokinase